Helge Stormorken

Helge Stormorken's AcademicInfluence.com Rankings

Helge Stormorken

Business

#1022

World Rank

#1121

Historical Rank

Management

#435

World Rank

#468

Historical Rank

business Degrees

Download Badge

Business

Why Is Helge Stormorken Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Helge Stormorken was a Norwegian veterinarian and physician. Research and organisational activity He established the cause of a worldwide fatal bleeding disease in pigletss leading to its eradication. He described the multifaceted Stormorken syndrome, a mutations in f. VII, f. IX, Fibrinogen Oslo IV and V, all with clinical consequences. Nearly thirty theses on different aspects emanated from the institute together with a host of single papers from its own staff and the many US and European visitors. The most prominent of these was Holm Holmsen who made basic discoveries establishing platelets as secretory non-nucleated cells. Stormorken was active in international organisations within the field, as chairman of the International Society on Thrombosis and Haemostasis 1978–1982, as cofounder and member of the governing board in European Thrombosis Research Organisation 1972–1978, as an honorary member in 1997. In 1971 Oslo and his institute was chosen as the organizer and host of the first international congress in this field.

(See a Problem?)

Helge Stormorken's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Blood Platelet Count and Function Are Related to Total and Cardiovascular Death in Apparently Healthy Men (1991) (396)
The blood platelet release reaction. (2009) (255)
Prevention of arterial thromboembolism with acetylsalicylic acid. A controlled clinical study in patients with aortic ball valves. (1977) (178)
A Dominant STIM1 Mutation Causes Stormorken Syndrome (2014) (150)
Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality. (2000) (145)
Effect of various contrast media on coagulation, fibrinolysis, and platelet function. An in vitro and in vivo study. (1986) (113)
Influence of fibrinogen on the aggregation of washed human blood platelets induced by adenosine diphosphate, thrombin, collagen, and adrenaline. (1965) (82)
A new assay for factor V (proaccelerin-accelerin) using Russell's viper venom. (1960) (80)
Species specificity of tissue thromboplastin. (1984) (73)
The preparation of proaccelerin deficient (parahemophilia) plasma for the assay of proaccelerin. (1957) (72)
Plasma Antithrombin III and Factor VIII Antigen in Relation to Angiographic Findings, Angina and Blood Groups in Middle-Aged Men (1977) (71)
Studies on the Haemostatic Defect in a Complicated Syndrome (1995) (58)
Ultrastructural studies on the platelet plug formation in bleeding time wounds from normal individuals and patients with von Willebrand's disease. (1974) (58)
A new syndrome: thrombocytopathia, muscle fatigue, asplenia, miosis, migraine, dyslexia and ichthyosis (1985) (58)
Adenine nucleotide metabolism of blood platelets. VII. ATPases: subcellular localization and behaviour during the thrombin-platelet interaction. (1968) (57)
Haematocrit: a predictor of cardiovascular mortality ? (1993) (54)
The release reaction of secretion. (1969) (48)
The purification of a human plasma kallikrein with weak plasminogen activator activity. (1978) (43)
Haemostatic studies in osteogenesis imperfecta. (2009) (42)
Fibromyalgia: family clustering and sensory urgency with early onset indicate genetic predisposition and thus a "true" disease. (1992) (41)
ABO blood groups and coronary heart disease (CHD). A study in subjects with severe and latent CHD. (1980) (39)
The effect of different stimuli on milk ejection and diuresis in the lactating cow. (1960) (39)
A study of the in vitro and in vivo effects of a synthetic heparin-like anticoagulant: dextran sulphate. (1957) (39)
Visualization of von Willebrand Factor Multimers by Enzyme-Conjugated Secondary Antibodies (1986) (39)
The discovery of factor V: a tricky clotting factor (2003) (37)
Homozygous truncation of the fibrinogen A alpha chain within the coiled coil causes congenital afibrinogenemia. (2000) (37)
Effect of linseed oil on platelet adhesiveness and bleeding-time in patients with coronary heart-disease. (1965) (36)
A Study of a Case of Congenital Hypoprothrombinaemia (1959) (36)
Effects of Ionic and Nonionic Contrast Media on Endothelium and on Arterial Thrombus Formation (1996) (35)
Influence of acetylsalicylic acid, butazolidine, colchicine, hydrocortisone, chlorpromazine and imipramine on the phagocytosis of polystyrene latex particles by human leucocytes. (1971) (34)
Tolerance and Excretion of Iohexol after Intravenous Injection in Healthy Volunteers (1980) (34)
Platelets, thrombosis and hemolysis. (1971) (33)
Platelet adhesiveness to glass beads. Methodological investigations using automatic platelet counting. (1965) (29)
Mutation Spectrum in Patients with Wiskott-Aldrich Syndrome and X-linked Thrombocytopenia: Identification of Twelve Different Mutations in the WASP Gene (1996) (27)
Characterization of a Factor VII Molecule Carrying a Mutation in the Second Epidermal Growth Factor-like Domain (1998) (27)
Hereditary α2-antiplasmin deficiency (1983) (25)
Chronic Effect of Smoking on Platelet Count and “Platelet Adhesiveness” in Presumably Healthy Middle-Aged Men (1977) (25)
The value of activated coagulation time in monitoring heparin therapy during extracorporeal circulation. (1984) (25)
Diagnosis of Heterozygotes in Glanzmann’s Thrombasthenia (1982) (25)
Immunologic quantification of fibrin deposition in thrombi formed in flowing native human blood (1996) (24)
The Release of ADP from Red Blood Cells (1968) (22)
X-Linked Thrombocytopenia and Thrombocytopathia: Attenuated Wiskott-Aldrich Syndrome (1991) (22)
Fibrinolytic activity of leucocytes in smears of bone marrow and peripheral blood. (2009) (22)
Species differences of clotting factors in ox, dog, horse, and man: thromboplastin and proconvertin. (1957) (22)
Reactivity of Stored Plasma to Thrombin, with Reference to the Fibrinogen Conversion Accelerator and Heparinoid Activity (1957) (21)
Hemostatic risk factors in arterial thrombosis and atherosclerosis: the thrombin-fibrin and platelet-vWF axis. (1997) (21)
Subcellular localization of platelet factor 3 and platelet factor 4. (2009) (20)
Reduced thrombus formation in native blood of homozygous factor VII-deficient patients at high arterial wall shear rate. (1994) (19)
Antifibrinolytic treatment with tranexamic acid (AMCA) in pediatric urinary tract surgery. (1970) (19)
Thrombocytopenic Bleedings in Young Pigs due to Maternal Isoimmunization (1963) (19)
Chromogenic Substrate Assay of Plasma Prekallikrein (1978) (18)
[Hemostasis in liver disease]. (1963) (18)
Relation of the Fibrinolytic to Other Biological Systems (1975) (18)
Kinetic studies on the breakdown of adenosine diphosphate in human plasma. (1965) (17)
Effects of Contrast Media on the Hemostatic and Thrombotic Mechanisms (1988) (17)
Role of ADP and thromboxanes in human thrombus formation in ex vivo models. (1997) (16)
A New Era in the Laboratory Evaluation of Coagulation and Fibrinolysis (1976) (16)
Species differences of clotting factors in ox, dog, horse, and man: proaccelerin and accelerin. (1957) (16)
FIRST-TRIMESTER DIAGNOSIS OF WISKOTT-ALDRICH SYNDROME BY DNA MARKERS (1989) (16)
Platelet adhesiveness in coronary heart disease. Evaluation of the plateletrich plasma-ADP method. (2009) (15)
Lupus anticoagulant: a unique case with lupus anticoagulant and habitual abortion together with antifactor II antibody and bleeding tendency. (1988) (15)
Platelet α2-antiplasmin is located in the platelet α-granules (1983) (15)
Comparison of glass adhesiveness and rate of aggregation of blood platelets. (1967) (15)
Species differences of clotting factors in ox, dog, horse, and man; thrombin and fibrinogen. (1957) (15)
Von Willebrand factor and cardiovascular risk. (1986) (14)
Diet and Histamine in the Ruminant (1963) (14)
[Stormorken's syndrome]. (2002) (14)
The thrombo-haemorrhagic balance. (2009) (14)
Tolerability of Iohexol after Injection into Healthy Volunteers (1983) (14)
Contrast Media Effects on Hemostatic and Thrombotic Parameters (1995) (13)
A peptide sequence from the EGF-2 like domain of FVII inhibits TF-dependent FX activation. (1997) (13)
The effect of trypsin on blood coagulation and the mechanism of its action. (1956) (12)
The use of buffers in blood coagulation studies. (1956) (12)
Dissociation of the aggregating effect and the inhibitory effect upon cyclic adenosine monophosphate accumulation by adrenaline and adenosine diphosphate in human platelets. (1987) (12)
A new bleeding disorder: lack of platelet aggregatory response to adrenaline and lack of secondary aggregation to ADP and platelet activating factor (PAF). (1983) (12)
Thrombosis prophylaxis with dextran and warfarin in vascular operations. (1972) (11)
Increased binding to ADP-stimulated platelets and aggregation effect of the dysfibrinogen Oslo I as compared with normal fibrinogen. (2009) (10)
Adenine nucleotides, serotonin, and aggregation properties of platelets of blue foxes (Alopex lagopus) with the Chediak-Higashi syndrome. (1990) (10)
Acute iron intoxication with abruptly reduced levels of vitamin K-dependent coagulation factors. (2009) (10)
The toxicity of red squill and scilliroside to rats and mice. (2009) (10)
Characterisation of cell-surface procoagulant activities using a microcarrier model. (1996) (10)
Intravascular haemolysis, platelet consumption and platelet adhesiveness in patients with prosthetic heart valves. (1971) (10)
Interrelations between the Clotting and Kinin Systems (1973) (10)
Iohexol, platelet activation and thrombosis (1998) (10)
Physiopathology of hemostasis. (1971) (10)
Electronic platelet counting. (1971) (9)
The platelet release reaction. Its general aspects and relation to phagocytosis-pinocytosis. (1969) (9)
Two-dimensional electrophoretic characterization (iso-dalt) of fibrinogen and fibrin subunit chains from four different genetic dysfibrinogen variants (1983) (9)
The Effect of Heparin on the Bleeding Time (1960) (9)
In vitro platelet degranulation by contrast media: clinical relevance? (1994) (9)
Species differences of clotting factors in ox, dog, horse, and man: prothrombin. (1957) (8)
Present state of contrast media as related to thromboembolic complications. (1991) (8)
Hemophilia BM in a female. (1985) (7)
Interrelations between the coagulation-, the fibrinolytic and the kallikrein-kinin system. (2009) (7)
Iohexol, platelet activation and thrombosis (1998) (7)
The discovery of Mary's mutation (2003) (7)
A new case of total kininogen deficiency. (1990) (6)
Epidemiological studies. Relation between dietary fat and arterial and venous thrombosis. (1973) (6)
The Fletcher factor-prekallikrein deficiency: a diagnostic test which identifies heterozygotes. (1974) (6)
STUDIES ON COAGULATION AND FIBRINOLYSLS IN BLOOD FROM PUERPERAL WOMEN WITH AND WITHOUT OESTROGEN TREATMENT (1975) (6)
On the pharmacology of the isolated sensitized guinea pig lung. (1959) (6)
Blood clotting, plasma kinins and fibrinolysis. (1970) (6)
Arterial Thromboembolism and Prosthetic Heart Valves. Effects of Acetylsalicylic Acid (1975) (5)
A new hereditary syndrome with a bleeding tendency, extreme miosis, spasms, dyslexia, thrombocytopathia etc. (1992) (5)
Diet and histamine in the ruminant. Occurrence of histamine in silage. (1962) (5)
Interrelations between the clotting and kinin systems. Activation of factor VII involving prekallikrein-kallikrein. A review. (1973) (5)
[Treatment of hemophiliacs with antibodies to factor VIII]. (1986) (5)
Pharmacologic effects of iopentol after intravenous injection in healthy volunteers. Preliminary report. (1987) (5)
An attempt to assay the 'Anti-Willebrand Factor'. (1965) (5)
[Release mechanisms]. (1972) (4)
Concomitant occurrence of mucopolysaccharidosis IIIB and Glanzmann's thrombasthenia. Further evidence of a hyperactive α‐N‐acetylglucosaminidase‐producing allele (1992) (4)
Platelet function related to the development and presenting symptoms in coronary artery disease. An epidemiological study in apparently healthy men. (2009) (4)
A new constellation: females with concomitant von Willebrand's disease and carriership for factor VIII. (1982) (4)
Platelets and megakaryocytes. I. Comments and dedication to Arvid Hellem. (1985) (4)
[Frequent urination--an important diagnostic marker in fibromyalgia]. (2005) (4)
Characterisation of Fibrinogen Oslo IV by Electrospray Mass Spectrometry (1997) (4)
The inherited basis for venous thrombosis. The thrombohaemorrhagic balance. (2009) (4)
The antiserotonin effect of the benzyl analog of bufotenin (BAB) and the benzyl analog of serotonin (BAS) in the isolated guinea pig lung. (1959) (3)
Platelet alpha 2-antiplasmin is located in the platelet alpha-granules. (1983) (3)
Effect of iopentol on coagulation and platelet function in vitro and in vivo. (1987) (3)
Adverse reactions to contrast media: related to medium or procedure? Observations on a case. (1988) (3)
[Fibrinolytic purpura; report of a case with acute myelogenous leukemia]. (1956) (3)
Chromogenic substrate assay of plasma prekallikrein. With a note on its site of biosynthesis. (1978) (3)
A novel gene mutation in the 60s loop of human coagulation factor VII – inhibition of interdomain crosstalk (2003) (2)
The hemostatic mechanism: the role of platelets in physiology and bleeding states. (1987) (2)
The passage of ether from mother to foetus. (2009) (2)
[Why do most of the Nobel Prizes go to USA?]. (2009) (2)
The mechanism of blood coagulation. (1973) (2)
Effect of pyridoxine on some haemostatic parameters. (1983) (2)
Severe factor VIII deficiency in a chromosomally normal female. (1986) (2)
[Month of birth and prevalence of fibromyalgia]. (1994) (2)
Vesical Hemorrhages in Male Aleutian Mink Caused by Hypersensitivity to Sulphadimidine (1970) (2)
On the pharmacology of methoxamine. (1959) (2)
The release reaction. (1972) (2)
National quality control screenings of coagulation analysis in Norway. (2009) (1)
Haematocrit: A Predictor of Cardiovascular Mortality? (1994) (1)
[Liposis dolorosa. Its own entity or the common denominator for other lipoma-based diseases?]. (1987) (1)
Salicylates and Dicoumarol Revisited – Anything New under The Sun? (1995) (1)
Parameters of hemostasis in Epidermolysis bullosa: absence of significant deviations from normal. (1966) (1)
[Use of heparin in pregnancy]. (1977) (1)
64. Afibrinogenemia due to homozygous CGA ??? TGA mutation in exon 4 of the fibrinogen A??-gene (1998) (1)
[Acetylsalicylic acid in the prevention of arterial thrombosis. Dosage problems in general and in the authors' experiment]. (1990) (1)
[When the knowledge on alloimmune antibody formation came about]. (2009) (1)
The Isolation of a Potent Plasma Kallikrein with Weak Plasminogen Activator Activity (1977) (1)
No effect of ovalbumin on the thrombin/fibrinogen reaction. (1981) (1)
Polymorphism of a platelet polypeptide. (1990) (1)
Von Willebrand Factor (vWF) - Why Are the Largest Multimers Most Efficient in Hemostasis? (1990) (1)
The Fernstrøm Prize 2002 for Margareta and Birger Blombäck. (2003) (0)
Contents, Vol. 2, 1973-74 (2004) (0)
Factor VIII Levels and Blood Group Antigens (1984) (0)
[Paul A. Owren--a 100 years' anniversary]. (2005) (0)
Quality Control of Thrombotest (TT) and Normotest (NT) (1969) (0)
Oral anticoagulation. (1979) (0)
Haemophilia A in Samojed Dog (2009) (0)
Epidemiological studies. (1989) (0)
Disrespectful thoughts on dimensions in the outer and inner world (2004) (0)
[Use of Octa V.I. in patients with severe hemophilia]. (1989) (0)
[PROBLEMS OF LABORATORY TECHNICIANS]. (1965) (0)
[The "diffuse" health problems of women]. (1999) (0)
[Present state of anticoagulation therapy]. (1971) (0)
1 THE NORMAL BLOOD PLATELET AND ITS FUNCTION (1979) (0)
[Subcutaneous heparin in prevention of post-operative thrombosis]. (1976) (0)
[Contraceptive pills and myocardial infarct]. (1975) (0)
[Acetylsalicylic acid. The dosage question]. (1987) (0)
Assay of prothrombin. (1958) (0)
[Anticoagulation treatment. Patients in whom administration is difficult]. (1972) (0)
Diseases due to factor-V-deficiency. (1962) (0)
Activation of Factor 7 in oral contraception. (1971) (0)
[Anti-adhesion and anti-coagulant substances in thrombosis therapy. Acetylsalicylic acid and Persantin in the spotlight]. (1971) (0)
Oral contraceptives and thrombosis (1970) (0)
Spontaneous (Unexplained) Thrombosis: The Inherited Basis for the Thrombohemorrhagic Balance (2020) (0)
[Thrombosis risks with estrogen treatment during the climacteric]. (1977) (0)
The Activation Sequence of The Clotting, Kinin and Fibrinolytic Systems (1977) (0)
[Overactive bladder syndrome]. (2005) (0)
Mechanism of bradycardia by methoxamine. (1959) (0)
Fibrinolytic vessel wall activator in arterial thrombosis. (1984) (0)
[Platelet inhibitory agents in the prevention of infarct]. (1978) (0)
First Wright-Schulte Lecture (1976) (0)
[Re: New guidelines for antithrombotic therapy and thromboprophylaxis]. (2014) (0)
[Prophylaxis of postoperative thrombosis with small doses of heparin]. (1972) (0)
[The surveillance of anticoagulant treatment]. (1966) (0)
[The year's Jahre Prize winners: Paul A. Owren, Professor, M. O., National Hospital, Oslo]. (1969) (0)
AB0 Blood Groups and Coronary Heart Disease (CHD) (1980) (0)
[Progress in the treatment of mild hemophilia. Liberation of factor VIII from the vascular endothelium with 1-desamino-8-D-arginine vasopressin]. (1989) (0)
Subject Index Vol. 2, 1973/74 (1973) (0)
[Sophisticated diseases]. (2008) (0)
[Do we honour those who deserve to be honoured?]. (1995) (0)
From killing poison to life saving drug: the history behind "blood thinning" in thromboembolic diseases. (2002) (0)
[Oral contraceptives and thrombosis. Introduction]. (1970) (0)
[Oral contraceptives and antithrombin III]. (1985) (0)

This paper list is powered by the following services:

Other Resources About Helge Stormorken

en.wikipedia.org

What Schools Are Affiliated With Helge Stormorken?

Helge Stormorken is affiliated with the following schools:

University of Oslo